Medical specialists from Canada tagged as investigators in clinical trials studying Breast Neoplasms
Total 265 results
-
Tatiana ConradSeen in:
- Ontario, Newmarket, Stronach (Southlake) Regional Health Centre
Trials:- NCT05417516 (Principal Investigator)
Conditions: -
Tehmina AsifSeen in:
- Saskatchewan, Saskatoon, Saskatoon Cancer Centre
Trials:- NCT03763604 (Principal Investigator)
Conditions: -
Teresa Petrella, MD, MSc, FRCPCSeen in:
- Ontario, Toronto, Odette Cancer Centre/Sunnybrook Health Sciences Centre
Trials:- NCT01022086 (Principal Investigator)
-
Terry Ng, DrSeen in:
- Ontario, Ottawa, The Ottawa Hospital Cancer Center
Trials:- NCT04874064 (Sub-Investigator)
Conditions: -
Thang Nguyen, MDSeen in:
- Manitoba, Winnipeg, St. Boniface Hospital
Trials:- NCT03748550 (Sub-Investigator)
- NCT05692921 (Sub-Investigator)
-
Thierry M. MuanzaSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT03550391 (Principal Investigator)
- NCT03488693 (Principal Investigator)
- NCT03598257 (Principal Investigator)
Conditions: -
Thierry Muanza, DrSeen in:
- Quebec, Montréal, Jewish General Hospital
Trials:- NCT05866458 (Principal Investigator)
Conditions: -
Thomas Warkus, MDSeen in:
- Quebec, Montreal, CHUM
Trials:- NCT05358639 (Sub-Investigator)
-
Tim WhelanSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:- NCT04228991 (Principal Investigator)
Conditions: -
Timothy D. LymberiouSeen in:
- Quebec, Greenfield Park, CSSS Champlain-Charles Le Moyne
Trials:- NCT03488693 (Principal Investigator)
Conditions: -
Timothy J. WhelanSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre at Hamilton Health Sciences
Trials:- NCT03488693 (Principal Investigator)
Conditions: -
Tulin Cil, MD, MEdSeen in:
- Ontario, Toronto, Princess Margaret Hospital
Trials:- NCT01837225 (Sub-Investigator)
Conditions: -
Valerie ThebergeSeen in:
- Quebec, Quebec City, CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
- Quebec, Quebec City, CHU de Québec - Université Laval
- Quebec, Quebec City, CHU-de Québec-Université de Laval
- Quebec, Québec, CHUQ-Pavillon Hotel-Dieu de Quebec
Trials:- NCT04228991 (Principal Investigator)
- NCT03488693 (Principal Investigator)
- NCT04852887 (Principal Investigator)
- NCT05417516 (Principal Investigator)
- NCT05866458 (Principal Investigator)
-
Vanessa BernsteinSeen in:
- British Columbia, Victoria, British Columbia Cancer Agency - Vancouver Island
Trials:- NCT03763604 (Principal Investigator)
Conditions: -
Vanessa Samouëlian, MDSeen in:
- Quebec, Montreal, CHUM
Trials:- NCT05358639 (Sub-Investigator)
-
Victoria MandilarasSeen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, Royal Victoria Hospital, McGill University Health Centre
Trials:- NCT05194072 (Principal Investigator)
- NCT06131840 (Principal Investigator)
Conditions:- Carcinoma, Non-Small-Cell Lung;
- Adenoid Cystic Carcinoma;
- Ovarian Neoplasms;
- Fallopian Tube Neoplasms;
- Peritoneal Neoplasms;
- Endometrial Neoplasms;
- Cholangiocarcinoma;
- Triple Negative Breast Neoplasms;
- Gallbladder Carcinoma;
- HER2 Negative Breast Neoplasms;
- Hormone Receptor Positive Breast Neoplasms;
- Stomach Neoplasms;
- Small Cell Lung Carcinoma;
- Colorectal Neoplasms;
- Pancreatic Ductal Adenocarcinoma;
- Gastroesophageal Junction Adenocarcinoma
-
Virginia Lee, PhDSeen in:
- Quebec, Montreal, Cedar's Breast Clinic, Royal Victoria Hospital
Trials:- NCT05020561 (Sub-Investigator)
Conditions: -
Vivianne Freitas, MDSeen in:
- Ontario, Toronto, University Health Network
Trials:- NCT06268405 (Principal Investigator)
Conditions: -
Wey L Leong, MDSeen in:
- Ontario, Toronto, Princess Margaret Hospital
Trials:- NCT01837225 (Sub-Investigator)
Conditions: -
Wey-Liang LeongSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT04397185 (Principal Investigator)
Conditions: -
Wilson MillerSeen in:
- Quebec, Montreal, Jewish General Hospital
- Quebec, Montreal, Jewish General Hospital - Clinical Research Unit
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Wladyslawa CwajnaSeen in:
- Nova Scotia, Halifax, QEII Health Sciences Centre/Nova Scotia Health Authority
Trials:- NCT03488693 (Principal Investigator)
Conditions: -
Yvette DrewSeen in:
- British Columbia, Vancouver, BC Cancer Agency
Trials:- NCT02632448 (Principal Investigator)
-
Zahi MitriSeen in:
- British Columbia, Vancouver, BCCA-Vancouver Cancer Centre
Trials:- NCT04457596 (Principal Investigator)
Conditions:- Anatomic Stage IA Breast Cancer AJCC v8;
- Anatomic Stage II Breast Cancer AJCC v8;
- Anatomic Stage IIA Breast Cancer AJCC v8;
- Anatomic Stage IIB Breast Cancer AJCC v8;
- Anatomic Stage III Breast Cancer AJCC v8;
- Anatomic Stage IIIA Breast Cancer AJCC v8;
- Anatomic Stage IIIB Breast Cancer AJCC v8;
- Anatomic Stage IIIC Breast Cancer AJCC v8;
- Prognostic Stage I Breast Cancer AJCC v8;
- Prognostic Stage IA Breast Cancer AJCC v8;
- Prognostic Stage IB Breast Cancer AJCC v8;
- Prognostic Stage II Breast Cancer AJCC v8;
- Prognostic Stage IIA Breast Cancer AJCC v8;
- Prognostic Stage IIB Breast Cancer AJCC v8;
- Prognostic Stage III Breast Cancer AJCC v8;
- Prognostic Stage IIIA Breast Cancer AJCC v8;
- Prognostic Stage IIIB Breast Cancer AJCC v8;
- Prognostic Stage IIIC Breast Cancer AJCC v8;
- Invasive Breast Carcinoma;
- HER2 Positive Breast Carcinoma;
- Multifocal Breast Carcinoma;
- Synchronous Bilateral Breast Carcinoma
Clinical Trials on Breast Neoplasms
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Emory UniversityEisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, BreastUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy